🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/02/2023 | 104,02 | 105,81 | 101,75 | 103,46 | -3,29% | 3,90% | 16.229.900 |
| 01/02/2023 | 106,97 | 107,43 | 106,08 | 106,98 | -0,40% | 1,26% | 10.103.200 |
| 31/01/2023 | 106,10 | 107,44 | 105,90 | 107,41 | +1,24% | 1,45% | 7.938.900 |
| 30/01/2023 | 105,57 | 106,50 | 105,50 | 106,09 | +0,67% | 0,95% | 6.476.600 |
| 27/01/2023 | 106,21 | 106,68 | 105,11 | 105,38 | -1,39% | 1,48% | 7.784.900 |
| 26/01/2023 | 108,53 | 108,55 | 105,82 | 106,87 | -1,58% | 2,52% | 9.672.700 |
| 25/01/2023 | 108,71 | 109,93 | 108,33 | 108,59 | +0,06% | 1,47% | 6.168.000 |
| 24/01/2023 | 110,00 | 110,00 | 106,39 | 108,52 | -1,24% | 3,28% | 7.424.200 |
| 23/01/2023 | 109,93 | 110,36 | 109,17 | 109,88 | -0,05% | 1,08% | 8.998.800 |
| 20/01/2023 | 109,38 | 109,99 | 108,65 | 109,94 | +0,04% | 1,23% | 9.216.500 |
| 19/01/2023 | 108,44 | 110,18 | 108,10 | 109,90 | +1,02% | 1,92% | 6.772.900 |
| 18/01/2023 | 109,92 | 110,10 | 108,58 | 108,79 | -1,50% | 1,38% | 8.799.500 |
| 17/01/2023 | 112,03 | 112,49 | 110,32 | 110,45 | -1,60% | 1,94% | 10.241.100 |
| 13/01/2023 | 111,20 | 112,44 | 110,95 | 112,25 | +0,43% | 1,34% | 5.757.800 |
| 12/01/2023 | 110,92 | 112,10 | 110,03 | 111,77 | +0,63% | 1,87% | 8.914.800 |
| 11/01/2023 | 109,34 | 111,31 | 108,75 | 111,07 | +0,23% | 2,34% | 8.626.500 |
| 10/01/2023 | 110,56 | 112,01 | 109,88 | 110,81 | +0,39% | 1,93% | 12.122.800 |
| 09/01/2023 | 114,88 | 114,93 | 109,94 | 110,38 | -3,88% | 4,34% | 12.858.800 |
| 06/01/2023 | 114,32 | 115,49 | 114,05 | 114,84 | +1,06% | 1,26% | 8.632.300 |
| 05/01/2023 | 111,59 | 113,91 | 111,42 | 113,64 | +1,39% | 2,23% | 9.578.900 |
| 04/01/2023 | 112,32 | 112,61 | 111,24 | 112,08 | +0,85% | 1,22% | 8.698.600 |
| 03/01/2023 | 110,41 | 111,20 | 109,49 | 111,14 | +0,17% | 1,55% | 8.062.500 |
| 30/12/2022 | 111,23 | 111,42 | 110,12 | 110,95 | +0,12% | 1,17% | 5.498.600 |
| 29/12/2022 | 111,39 | 111,70 | 110,75 | 110,82 | -0,23% | 0,85% | 4.467.200 |
| 28/12/2022 | 112,89 | 112,89 | 111,06 | 111,08 | -0,93% | 1,62% | 5.107.800 |
| 27/12/2022 | 112,41 | 112,59 | 111,53 | 112,12 | +0,23% | 0,94% | 5.125.800 |
| 23/12/2022 | 111,25 | 112,13 | 110,87 | 111,86 | +0,56% | 1,13% | 4.547.400 |
| 22/12/2022 | 110,90 | 111,69 | 110,21 | 111,24 | +0,12% | 1,33% | 8.373.700 |
| 21/12/2022 | 110,10 | 111,19 | 109,54 | 111,11 | +1,28% | 1,50% | 6.640.900 |
| 20/12/2022 | 109,94 | 110,66 | 109,16 | 109,71 | +0,25% | 1,36% | 8.022.000 |